香港股市 將在 6 小時 47 分鐘 開市

Elekta AB (publ) (EKTAY)

OTC Markets OTCPK - OTC Markets OTCPK 延遲價格。貨幣為 USD。
加入追蹤清單
6.15-0.02 (-0.32%)
收市:11:06AM EDT

Elekta AB (publ)

Kungstensgatan 18
Box 7593
Stockholm 103 93
Sweden
46 8 58 72 54 00
https://elekta.com

版塊Healthcare
行業Medical Instruments & Supplies
全職員工4,500

描述

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services. It also provides Elekta Studio, an image guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; Geneva, an applicator for cervical cancer treatment; veterinary radiation therapy products; and Elekta Kaiku for personalized cancer care. In addition, the company offers stereotactic radiosurgery, such as Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for radiosurgeons; and Elekta Esprit. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System for minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.

公司管治

截至 2024年6月1日 止,Elekta AB (publ) 的 ISS 管治質素評分為 5。 Pillar 分數正在審核中:5;董事會:7;股東權利:8;現金賠償:1。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。